cutaneously into the right flank of age-matched mice. The growth of the solid tumors was followed by weekly palpations. Tumors grew equally well in B6 mice ofthe National Institutes of Health (Bethesda, MD) colony, the progenitor strain of the transgenic mice, and B6 mice from the Stockholm colony, our usual host for the serial transplantation of the RBL-5 lymphoma.
In Vivo NK Cell Depletion. 1 d before inoculation of tumor cells, each mouse either received an intravenous dose of 30 wl anti-asialo GM, antiserum, or an intraperitoneal injection of 200 ul anti-NK 1.1 mAb (ascites preparation) (8) . In the case of anti-asialo GM, antiserum, the mice received additional inoculations on day 3 and 7 after tumor cell inoculation .
In Vitro H-2 Typing. (D8 x B6)F, x B6 backcross mice were typed for expression of the D°antigen by a one step complement-dependent cytotoxicity test. The 34-5-8S (anti Dd) mAb, (obtained from the American Type Culture Collection, Rockville, MD) was used on inguinal lymphnode cells removed during general anesthesia. All mice that showed >50% specific killing were typed as Dd. . The majority of mice typed as positive showed >80% dead cells, while the majority of mice typed as negative showed <20% dead cells. Of 126 mice typed so far, 63 have been found Dd' and 63 Dd-.
Results and Discussion Tumor growth was followed after subcutaneous inoculation ofgraded doses ofRBL-5 lymphoma cells (H-2b) in mice of the C57BL/6 (B6) strain and of the H-21)d transgenic strain D8. Transgenic D8 mice were more resistant to inocula of 103 and 104 cells than the B6 mice (Table I) . F1 hybrids between D8 and B6 were all Dd' and rejected the RBL-5 lymphoma in a similar fashion as D8.
Tumor resistance segregated with Dd in (D8 x B6)F1 x B6 backcross mice. An inoculum of 104 cells grew out as tumors in 3 of 18 Dd' and in 17 of 18 Dd-backcross mice (Fig. 1 ). The 1 :1 distribution confirmed that the transgene segregated as a single dominant gene (6) . The integration site of the transgene is unknown, but linkage analysis studies have excluded a location site within or near the MHC (9) .
It has been previously found that the RBL-5 tumor is sensitive to Fl hybrid resistance (10), defined as the rejection of transplanted hematopoietic tissue or tumors of parental origin by F1 hybrids of two inbred strains (1, 5) . RBL-5 cells were rejected by all F1 hybrids and all backcross mice that carried the Dd gene (10, Table   I ). As shown by the dose titration experiments, (D8 x B6)Fl hybrids and B6 to congenic H-2D' strain F1 hybrids rejected RBL-5 cells equally well (Table I) .
Resistance of the Dd' backcross mice could be completely abrogated by either 400 rad irradiation or by anti-asialo GM, antibody treatment (Fig. 1 ). The same treatments are known to abrogate NK cell-mediated H-2-associated resistance to RBL-5 in conventional F1 and backcrosses, while T cell depletion by thymectomy and irradiation has no effect (11) (12) (13) . This suggests that NK cells are involved, which was confirmed here for the rejection in transgenic mice by treatment of the animals with the mAb anti-NK 1.1 (8, 14) . The tumors then grew equally well in D8, (D8 x B6)Fl, and B6 mice (Table I) . (D8 x B6)F1 hybrids were also resistant to threshold doses of two other B6 lymphomas, the rad-LV induced P52-127 .166 and the benzpyrene-induced EL-4 (Table I) . Our results with the D8 mice, and the association between resistance and Dd in the H-2-recombinant crosses lead to the conclusion that the lymphoma resistance is directly dependent on the Dd gene.
Apart from demonstrating that tumor rejection could be conveyed by a transgene, the results are pertinent for the interpretation of the MHC-linked control of Fl hybrid resistance . Recessive Hh antigens have been postulated to explain hybrid resistance to hematopoietic grafts (5). The Hh genes have been tentatively located to the D region of the H-2 complex, although rejection did not require expression of the 13 6 antigen on the graft (5, (15) (16) (17) . It was suggested that the H-2 6 -linked Hh-l' allele is only expressed in the homozygous H-2 616 parent that would be tolerant to the corresponding antigen product. Heterozygous H -2d16 mice would not express Hh-1 6 , with lack of tolerance and rejection of a Hh-1 6+ lymphoma graft as the con- (22, 23) , or acted less specifically, e. g., after the graft had been mispositioned in the transgenic mice by the action of other host cells (24) . It must be stressed that NK cells may have multiple recognition strategies and surveillance functions . Other NK-mediated host-graft or host-virus (25) interactions may therefore be H-2 independent. Furthermore, a system scanning for absence of self must not necessarily distinguish class I epitopes by the same criteria as T cells, which means that not every new H-2 allele introduced by an Fl cross or a transgene must lead to an altered picture of self from the point of view of NK cells. H-2-associated natural resistance as well as NK cells are effective in mice with severe combined immunodeficiency (26, 27) . These mice are defective with regard to Ig and TCR gene rearrangement (28) . With the direct evidence that class I genes are involved in natural resistance, one may ask if the MHC products have other immunological functions than presentation of peptides to receptors assembled from the a, Q, Y, and 8 TCR families. By the use of bone marrow chimera and exonshuffled genes, it may be possible to delineate the part of H-2D' required, and the time and site of its expression necessary to switch off "tolerance" in an NK-dependent system .
Summary
The H-2Dd transgenic strain D8 on C57BL background was more resistant to subcutaneous challenge ofRBL-5 lymphoma cells than B6 controls . The direct role of the H-2D d antigen was investigated by the use of (D8 x B6)F1 crosses and (D8 B6) x B6 backcrosses. The latter showed cosegregation with regard to Dd antigen expression and lymphoma resistance, both of which were inherited in a pattern consistent with control by a single dominant gene. The rejection potential in (D8 x B6)Fl mice appeared as strong as that seen in crosses between B6 and MHC congenic mice (on B10 background) carrying H-2V. The lymphoma resistance could be abrogated by treatment with anti-asialo GM, antiserum or anti-NK 1 .1 mAb, indicating a role for NK cells.
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